AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review

•Coexistence of AChR antibody and MuSK antibody is rare in children MG.•AChR–MG children can switch to MuSK–MG or double antibody positive MG.•The serological switch is accompanied by a switch in clinical phenotype to that of MuSK–MG. Muscle–specific tyrosine kinase antibody (MuSK–Ab) and acetylchol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromuscular disorders : NMD 2020-07, Vol.30 (7), p.534-538
Hauptverfasser: Lu, Yaru, Ran, Hao, Yang, Wenhao, Ma, Qian, Qiu, Li, Ou, Changyi, Chen, Pei, Lin, Zhongqiang, Liu, Weibin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 538
container_issue 7
container_start_page 534
container_title Neuromuscular disorders : NMD
container_volume 30
creator Lu, Yaru
Ran, Hao
Yang, Wenhao
Ma, Qian
Qiu, Li
Ou, Changyi
Chen, Pei
Lin, Zhongqiang
Liu, Weibin
description •Coexistence of AChR antibody and MuSK antibody is rare in children MG.•AChR–MG children can switch to MuSK–MG or double antibody positive MG.•The serological switch is accompanied by a switch in clinical phenotype to that of MuSK–MG. Muscle–specific tyrosine kinase antibody (MuSK–Ab) and acetylcholine receptor antibody (AChR–Ab) coexistence in myasthenia gravis (MG) is very rare. In this report, two children with AChR–Ab switching to double antibody positive MG (DP–MG) or MuSK–Ab positive MG (MuSK–MG) are described. Six similar cases were found in the literature via online database search. Therefore, this study describes eight patients in total, six female and two male. The average age of onset was 7.25 ± 5.95 years. Four AChR–MG patients switched to DP–MG with no known precipitating factor and four switched after thymectomy (two to MuSK–MG and two to DP–MG). After the serological switch, the patients transitioned to the phenotype of MuSK–MG and responded poorly to cholinesterase inhibitors and well to corticosteroids and plasma exchange.
doi_str_mv 10.1016/j.nmd.2020.03.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2401110210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960896620300857</els_id><sourcerecordid>2401110210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-b10b74d1f713ebedcc829e52f7f5d0d7ed71850026139334217678796a7aecb43</originalsourceid><addsrcrecordid>eNp9kE1v1DAURSMEotPCD2CDvGST8J6diROxqkYFKoqQ-Fhbjv3S8SiJB9uZ0Uj8eFxNYYVY3c29R7qnKF4hVAjYvN1V82QrDhwqEBUgf1KssJWi5KKpnxYr6Boo265pLorLGHcAuJaNfF5cCC5ayVuxKn5db7Zf2XTSMW1pdprdB31wkcWjS2br5nuWPPu8fPvEfGDWL_1ITM_J9d6e2N5Hl9yB_rF3M0tHzzJitIHmvLFsdImCTksgFujg6PiieDboMdLLx7wqfry_-b75WN59-XC7ub4rTY1dKnuEXtYWB4mCerLGtLyjNR_ksLZgJVmJ7RqANyg6IWqO-WUru0ZLTaavxVXx5szdB_9zoZjU5KKhcdQz-SUqXgMiAkfIVTxXTfAxBhrUPrhJh5NCUA_S1U5l6epBugKhsvS8ef2IX_qJ7N_FH8u58O5coHwyHw8qGkezIesCmaSsd__B_wbMWZO7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2401110210</pqid></control><display><type>article</type><title>AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review</title><source>ScienceDirect</source><creator>Lu, Yaru ; Ran, Hao ; Yang, Wenhao ; Ma, Qian ; Qiu, Li ; Ou, Changyi ; Chen, Pei ; Lin, Zhongqiang ; Liu, Weibin</creator><creatorcontrib>Lu, Yaru ; Ran, Hao ; Yang, Wenhao ; Ma, Qian ; Qiu, Li ; Ou, Changyi ; Chen, Pei ; Lin, Zhongqiang ; Liu, Weibin</creatorcontrib><description>•Coexistence of AChR antibody and MuSK antibody is rare in children MG.•AChR–MG children can switch to MuSK–MG or double antibody positive MG.•The serological switch is accompanied by a switch in clinical phenotype to that of MuSK–MG. Muscle–specific tyrosine kinase antibody (MuSK–Ab) and acetylcholine receptor antibody (AChR–Ab) coexistence in myasthenia gravis (MG) is very rare. In this report, two children with AChR–Ab switching to double antibody positive MG (DP–MG) or MuSK–Ab positive MG (MuSK–MG) are described. Six similar cases were found in the literature via online database search. Therefore, this study describes eight patients in total, six female and two male. The average age of onset was 7.25 ± 5.95 years. Four AChR–MG patients switched to DP–MG with no known precipitating factor and four switched after thymectomy (two to MuSK–MG and two to DP–MG). After the serological switch, the patients transitioned to the phenotype of MuSK–MG and responded poorly to cholinesterase inhibitors and well to corticosteroids and plasma exchange.</description><identifier>ISSN: 0960-8966</identifier><identifier>EISSN: 1873-2364</identifier><identifier>DOI: 10.1016/j.nmd.2020.03.012</identifier><identifier>PMID: 32387283</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Achr antibody ; Children ; Musk antibody ; Myasthenia gravis</subject><ispartof>Neuromuscular disorders : NMD, 2020-07, Vol.30 (7), p.534-538</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-b10b74d1f713ebedcc829e52f7f5d0d7ed71850026139334217678796a7aecb43</citedby><cites>FETCH-LOGICAL-c419t-b10b74d1f713ebedcc829e52f7f5d0d7ed71850026139334217678796a7aecb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.nmd.2020.03.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32387283$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Yaru</creatorcontrib><creatorcontrib>Ran, Hao</creatorcontrib><creatorcontrib>Yang, Wenhao</creatorcontrib><creatorcontrib>Ma, Qian</creatorcontrib><creatorcontrib>Qiu, Li</creatorcontrib><creatorcontrib>Ou, Changyi</creatorcontrib><creatorcontrib>Chen, Pei</creatorcontrib><creatorcontrib>Lin, Zhongqiang</creatorcontrib><creatorcontrib>Liu, Weibin</creatorcontrib><title>AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review</title><title>Neuromuscular disorders : NMD</title><addtitle>Neuromuscul Disord</addtitle><description>•Coexistence of AChR antibody and MuSK antibody is rare in children MG.•AChR–MG children can switch to MuSK–MG or double antibody positive MG.•The serological switch is accompanied by a switch in clinical phenotype to that of MuSK–MG. Muscle–specific tyrosine kinase antibody (MuSK–Ab) and acetylcholine receptor antibody (AChR–Ab) coexistence in myasthenia gravis (MG) is very rare. In this report, two children with AChR–Ab switching to double antibody positive MG (DP–MG) or MuSK–Ab positive MG (MuSK–MG) are described. Six similar cases were found in the literature via online database search. Therefore, this study describes eight patients in total, six female and two male. The average age of onset was 7.25 ± 5.95 years. Four AChR–MG patients switched to DP–MG with no known precipitating factor and four switched after thymectomy (two to MuSK–MG and two to DP–MG). After the serological switch, the patients transitioned to the phenotype of MuSK–MG and responded poorly to cholinesterase inhibitors and well to corticosteroids and plasma exchange.</description><subject>Achr antibody</subject><subject>Children</subject><subject>Musk antibody</subject><subject>Myasthenia gravis</subject><issn>0960-8966</issn><issn>1873-2364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAURSMEotPCD2CDvGST8J6diROxqkYFKoqQ-Fhbjv3S8SiJB9uZ0Uj8eFxNYYVY3c29R7qnKF4hVAjYvN1V82QrDhwqEBUgf1KssJWi5KKpnxYr6Boo265pLorLGHcAuJaNfF5cCC5ayVuxKn5db7Zf2XTSMW1pdprdB31wkcWjS2br5nuWPPu8fPvEfGDWL_1ITM_J9d6e2N5Hl9yB_rF3M0tHzzJitIHmvLFsdImCTksgFujg6PiieDboMdLLx7wqfry_-b75WN59-XC7ub4rTY1dKnuEXtYWB4mCerLGtLyjNR_ksLZgJVmJ7RqANyg6IWqO-WUru0ZLTaavxVXx5szdB_9zoZjU5KKhcdQz-SUqXgMiAkfIVTxXTfAxBhrUPrhJh5NCUA_S1U5l6epBugKhsvS8ef2IX_qJ7N_FH8u58O5coHwyHw8qGkezIesCmaSsd__B_wbMWZO7</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Lu, Yaru</creator><creator>Ran, Hao</creator><creator>Yang, Wenhao</creator><creator>Ma, Qian</creator><creator>Qiu, Li</creator><creator>Ou, Changyi</creator><creator>Chen, Pei</creator><creator>Lin, Zhongqiang</creator><creator>Liu, Weibin</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review</title><author>Lu, Yaru ; Ran, Hao ; Yang, Wenhao ; Ma, Qian ; Qiu, Li ; Ou, Changyi ; Chen, Pei ; Lin, Zhongqiang ; Liu, Weibin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-b10b74d1f713ebedcc829e52f7f5d0d7ed71850026139334217678796a7aecb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Achr antibody</topic><topic>Children</topic><topic>Musk antibody</topic><topic>Myasthenia gravis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Yaru</creatorcontrib><creatorcontrib>Ran, Hao</creatorcontrib><creatorcontrib>Yang, Wenhao</creatorcontrib><creatorcontrib>Ma, Qian</creatorcontrib><creatorcontrib>Qiu, Li</creatorcontrib><creatorcontrib>Ou, Changyi</creatorcontrib><creatorcontrib>Chen, Pei</creatorcontrib><creatorcontrib>Lin, Zhongqiang</creatorcontrib><creatorcontrib>Liu, Weibin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuromuscular disorders : NMD</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Yaru</au><au>Ran, Hao</au><au>Yang, Wenhao</au><au>Ma, Qian</au><au>Qiu, Li</au><au>Ou, Changyi</au><au>Chen, Pei</au><au>Lin, Zhongqiang</au><au>Liu, Weibin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review</atitle><jtitle>Neuromuscular disorders : NMD</jtitle><addtitle>Neuromuscul Disord</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>30</volume><issue>7</issue><spage>534</spage><epage>538</epage><pages>534-538</pages><issn>0960-8966</issn><eissn>1873-2364</eissn><abstract>•Coexistence of AChR antibody and MuSK antibody is rare in children MG.•AChR–MG children can switch to MuSK–MG or double antibody positive MG.•The serological switch is accompanied by a switch in clinical phenotype to that of MuSK–MG. Muscle–specific tyrosine kinase antibody (MuSK–Ab) and acetylcholine receptor antibody (AChR–Ab) coexistence in myasthenia gravis (MG) is very rare. In this report, two children with AChR–Ab switching to double antibody positive MG (DP–MG) or MuSK–Ab positive MG (MuSK–MG) are described. Six similar cases were found in the literature via online database search. Therefore, this study describes eight patients in total, six female and two male. The average age of onset was 7.25 ± 5.95 years. Four AChR–MG patients switched to DP–MG with no known precipitating factor and four switched after thymectomy (two to MuSK–MG and two to DP–MG). After the serological switch, the patients transitioned to the phenotype of MuSK–MG and responded poorly to cholinesterase inhibitors and well to corticosteroids and plasma exchange.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>32387283</pmid><doi>10.1016/j.nmd.2020.03.012</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-8966
ispartof Neuromuscular disorders : NMD, 2020-07, Vol.30 (7), p.534-538
issn 0960-8966
1873-2364
language eng
recordid cdi_proquest_miscellaneous_2401110210
source ScienceDirect
subjects Achr antibody
Children
Musk antibody
Myasthenia gravis
title AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AChR%20myasthenia%20gravis%20switching%20to%20MuSK%20or%20double%20antibody%20positive%20myasthenia%20gravis%20in%20two%20children%20and%20literature%20review&rft.jtitle=Neuromuscular%20disorders%20:%20NMD&rft.au=Lu,%20Yaru&rft.date=2020-07-01&rft.volume=30&rft.issue=7&rft.spage=534&rft.epage=538&rft.pages=534-538&rft.issn=0960-8966&rft.eissn=1873-2364&rft_id=info:doi/10.1016/j.nmd.2020.03.012&rft_dat=%3Cproquest_cross%3E2401110210%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2401110210&rft_id=info:pmid/32387283&rft_els_id=S0960896620300857&rfr_iscdi=true